Reevaluating the role of phosphodiesterase inhibitors in the treatment of cardiovascular disease-Reference-Cited by-同舟云学术

Reevaluating the role of phosphodiesterase inhibitors in the treatment of cardiovascular disease

Published:2002-06 Issue:6 Volume:25 Page:256-262
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Feldman Arthur M.,McNamara Dennis M.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference43 articles.

1. Cardiotonic activity of amrinone-Win 40680 [5-amino-3,4′-bipyridine-6(1H)-one];Alousi;Circ Res,1979

2. Influence of caffeine and other methylxanthines on mechanical properties of isolated mammalian heart muscle. Evidence for a dual mechanism of action;Blinks;Circ Res,1972

3. Direct vasodilator and positive inotropic actions of amrinone;Millard;J Mol Cell Cardiol,1980

4. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle;Endoh;J Pharmacol Exper Ther,1982

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association Between Pentoxifylline Use and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Multi-Institutional Cohort Study;Biomedical Journal;2024-07

2. Phosphodiesterase Inhibitors;Heart Failure in the Child and Young Adult;2018

3. Phosphodiesterase type 2 distribution in the guinea pig urinary bladder;World Journal of Urology;2014-12-06

4. Toward Safe Inotropic Therapy;Journal of Cardiovascular Pharmacology;2014-10

5. Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart;J GERIATR CARDIOL;2014